Novo Nordisk has recalled 30 batches of a prefilled insulin product following a dosage error at a manufacturing facility in China.
Source: http://www.in-pharmatechnologist.com/Regulatory-Safety/China-plant-dosage-error-leads-to-insulin-recall-for-Novo-Nordisk
